COVIDVaxStories: Randomized Trial to Reduce COVID-19 Vaccine Hesitancy in Populations of Color
Conditions: Vaccine Hesitancy Interventions: Behavioral: Storytelling; Behavioral: Learn More (Active Comparator) Sponsors: University of Massachusetts, Worcester; Merck Sharp& Dohme LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS)
DiscussionAlthough ME/CFS including PACS-CFS causes an immense individual, social, and economic burden, we lack efficient therapeutic options. The present study aims to investigate the efficacy of immunoadsorption and to contribute to the etiological understanding and establishment of diagnostic tools for ME/CFS.Trial registrationRegistration Number:NCT05710770. Registered on 02 February 2023. (Source: Trials)
Source: Trials - March 7, 2024 Category: Research Source Type: clinical trials
Impact of COVID-19 Pandemic on Headache Evaluations in the Pediatric Emergency Department
Conditions: COVID-19; Headache Disorders; Emergency Service, Hospital Sponsors: Fondazione IRCCS Ca ' Granda, Ospedale Maggiore Policlinico Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
An E-health Psychoeducation for People With Bipolar Disorders
Conditions: Bipolar Disorder; Psychoeducation; COVID-19 Pandemic Interventions: Other: e-health psychoeducation Sponsors: University of Cagliari; Alessandra Perra Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
Impact of COVID-19 Pandemic on Epilepsy Evaluations in the Pediatric Emergency Department
Conditions: Epilepsy; Emergency Services, Hospital; COVID-19 Sponsors: Fondazione IRCCS Ca ' Granda, Ospedale Maggiore Policlinico Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
Sulfureous Water Therapy in Viral Respiratory Diseases
Conditions: Long-COVID; Post COVID-19 Condition; Chronic COVID-19 Syndrome; Post Acute Sequelae of COVID-19 Interventions: Other: Inhalation of Sulfurous Thermal Water; Other: Inhalation of Sterile Distilled non-pyrogenic Water Sponsors: University of Roma La Sapienza; Universit à degli studi di Roma Foro Italico; Queen Mary University of London; Bios Prevention Srl Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
Evaluation of KGR Prescriptions in Suppressing COVID-19 Infection.
Conditions: Coronavirus Disease 2019; Severe Acute Respiratory Syndrome Coronavirus 2 Infection Interventions: Combination Product: Kang Guan Recipe (Treat); Combination Product: Kang Guan Recipe (Placebo) Sponsors: Sheng-Teng Huang Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Clinical Trial of the Safety and Efficacy of Peripheral Nerve Stimulation in the Treatment of Postherpetic Neuralgia.
Conditions: Neuropathic Pain; Postherpetic Neuralgia Interventions: Device: Active electrostimulation; Device: Placebo electrostimulation Sponsors: Wuhan Union Hospital, China; Xinhua Hospital, Shanghai Jiao Tong University School of Medicine; The Second People ' s Hospital of GuangDong Province; Xiamen Hospital of Traditional Chinese Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Ocular Trauma and COVID-19 in Indonesia
Conditions: Ophthalmological Disorder; Ocular Injury; COVID-19 Sponsors: Prof. R. D. Kandou General Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
A Study to Learn About the Use of Paxlovid in Patients With COVID-19 in the Kingdom of Bahrain.
Conditions: COVID-19 Interventions: Drug: nirmatrelvir, ritonavir; Other: Controls Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Phase 3 Study of the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine
Conditions: COVID-19 Interventions: Biological: CIC Vaccine Co-formulated tNIV2 , SARSCoV-2 rS and Matrix-M Adjuvant; Biological: Novavax COVID-19 Vaccine; Biological: Comparator Influenza Vaccine - Fluarix; Biological: Comparator Influenza Vaccine -Fluarix High Dose; Biological: Placebo 0.9% sodium chloride for injection Sponsors: Novavax Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Phase II Clinical Study of SHEN211 Tablets in the Treatment of Mild and Moderate Novel Corona Virus Infection (COVID-19)
Conditions: COVID-19 Interventions: Drug: SHEN211 Tablets; Procedure: Placebo for SHEN211 Tablets Sponsors: JKT Biopharma Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
SHEN211 Tablets for the Treatment of Mild and Moderate Novel Corona Virus Infections (COVID-19)
Conditions: COVID-19 Interventions: Drug: SHEN211 Tablets; Procedure: Placebo for SHEN211 Tablets Sponsors: JKT Biopharma Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical Outcomes
Conditions: COVID-19 Sponsors: Singapore Health Services Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 29, 2024 Category: Research Source Type: clinical trials
Deep Learning Model Predicts Pathological Complete Response of Lung Cancer Following Neoadjuvant Immunochemotherapy
Conditions: Deep Learning Model; Pathological Complete Response; Non-small Cell Lung Cancer; Neoadjuvant Chemoimmunotherapy Interventions: Diagnostic Test: No interventions Sponsors: Wuhan Union Hospital, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 29, 2024 Category: Research Source Type: clinical trials
